Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters
Public ClinicalTrials.gov record NCT05383274. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT05383274
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Urotronic Inc.
- Industry
- Enrollment
- 34 participants
Conditions and interventions
Conditions
Interventions
- Optilume Urethral DCB Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 22 Years to 65 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 13, 2022
- Primary completion
- Jun 29, 2026
- Completion
- Dec 29, 2026
- Last update posted
- Apr 27, 2026
2022 – 2026
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Urology | Little Rock | Arkansas | 72211 | Recruiting |
| Orlando Health | Orlando | Florida | 32806 | Recruiting |
| Florida Urology | Tampa | Florida | 33615 | Recruiting |
| Regional Urology | Shreveport | Louisiana | 71106 | Completed |
| Chesapeake | Hanover | Maryland | 21076 | Completed |
| Freedman Urology | Las Vegas | Nevada | 89144 | Recruiting |
| New Jersey Urolgy | Millburn | New Jersey | 07041 | Completed |
| Western New York | Cheektowaga | New York | 14225 | Recruiting |
| Urology Clinics of North Texas | Dallas | Texas | 75231 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05383274, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05383274 live on ClinicalTrials.gov.